The EML4-ALK fusion protein mediates reduced sensitivity to the combination of neratinib and dasatinib

被引：0
|
作者：
Castel, Myra E.
Conlon, Neil T.
Eli, Lisa D.
Wong, Alvin
Crown, John
Collins, Denis M.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-4041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4041
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EML4-ALK fusion gene expressing transgenic mouse for lung cancer model
    Pyo, Kyoung-Ho
    Kim, Hye Ryun
    Lim, Sun Min
    Yun, Mi Ran
    Kim, Sung-Moo
    Kim, Hwan
    Kang, Han Na
    Lee, Ji Min
    Kim, Sang Gyun
    Cho, Byoung Chul
    CANCER RESEARCH, 2016, 76
  • [42] Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma
    Quan Jiang
    Han-Xing Tong
    Ying-Yong Hou
    Yong Zhang
    Jing-Lei Li
    Yu-Hong Zhou
    Jing Xu
    Jiong-Yuan Wang
    Wei-Qi Lu
    Orphanet Journal of Rare Diseases, 12
  • [43] EML4-ALK fusion gene in non-small cell lung cancer
    Lei, Yu
    Lei, Yan
    Shi, Xiang
    Wang, Jingjing
    ONCOLOGY LETTERS, 2022, 24 (02)
  • [44] Identification of EML4-ALK as an alternative fusion gene in epithelioid inflammatory myofibroblastic sarcoma
    Jiang, Quan
    Tong, Han-Xing
    Hou, Ying-Yong
    Zhang, Yong
    Li, Jing-Lei
    Zhou, Yu-Hong
    Xu, Jing
    Wang, Jiong-Yuan
    Lu, Wei-Qi
    ORPHANET JOURNAL OF RARE DISEASES, 2017, 12
  • [45] Presence of an EML4-ALK gene fusion detected by microfluidic chip DNA hybridization
    Boparai, Montek
    Oberc, Christopher
    Li, Paul C. H.
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2021, 85 (02) : 197 - 204
  • [46] Analysis of EML4-ALK fusion transcripts in plasma and platelets to monitor response to crizotinib in EML4-ALK positive non-small cell lung cancer patients (NSCLC)
    Aguado, Cristina
    Teixido, Cristina
    Gimenez-Capitan, Ana
    Gil, Maria de los Llanos
    Rodriguez, Sonia
    Viteri, Santiago
    Karachaliou, Niki
    Aldeguer, Erika
    Peg, Vicente
    Alonso, Lidia
    Molina-Vila, Miguel Angel
    Rosell, Rafael
    CANCER RESEARCH, 2017, 77
  • [47] A Novel EML4-ALK Variant Exon 6 of EML4 Fused to Exon 19 of ALK
    Penzel, Roland
    Schirmacher, Peter
    Warth, Arne
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (07) : 1198 - 1199
  • [48] ALK inactivation induced acquired resistance to alectinib in lung cancer harboring EML4-ALK fusion gene
    Isozaki, Hideko
    Ichihara, Eiki
    Yasugi, Masayuki
    Nobuaki, Ochi
    Hotta, Katsuyuki
    Takigawa, Nagio
    Sendo, Toshiaki
    Tanimoto, Mitsune
    Kiura, Katsuyuki
    CANCER RESEARCH, 2014, 74 (19)
  • [49] ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 and sensitizes EML4-ALK variant 3 to crizotinib
    Guan, Jikui
    Chuang, Tzu-Po
    Vikstrom, Anders
    Palmer, Ruth H.
    Hallberg, Bengt
    FRONTIERS IN ONCOLOGY, 2024, 13
  • [50] Two novel EML4-ALK fusion variants involving EML4 exon 17 identified in lung cancer
    Li, Hai-Rong
    Sanders, Heather R.
    Sferruzza, Anthony D.
    Novic, Connie
    Meloni-Ehrig, Aurelia M.
    Albitar, Maher
    CANCER RESEARCH, 2010, 70
12345